Why should we treat obstructive sleep apnoea?

David Cunnington, Jun Keng Khoo



Obstructive sleep apnoea is a common condition that has been shown to impact cardiovascular and other health and quality of life outcomes. What have we learned from the recently published SAVE study – the largest intervention study in obstructive sleep apnoea?

Article Extract

  • Obstructive sleep apnoea (OSA) is a common condition that can significantly impact health, accident risk and quality of life.
  • OSA is associated with increased cardiovascular risk.
  • In people with significant OSA and existing cardiovascular or cerebrovascular disease, treatment with continuous positive airway pressure (CPAP) does not appear to reduce the risk of future cardiovascular events.
  • Treatment should be individualised according to symptoms, comorbidities and patient factors such as fatigue-critical occupation.

Picture credit: © BSIP/
Model used for illustrative puroses only